Apollo Health Ventures is a transatlantic venture capital firm and company builder headquartered in Berlin, with additional presence in the United States. The firm focuses on biotechnology, longevity, health platforms, and related technologies, typically at seed and Series A stage.

Apollo has built a strong reputation through a venture creation model and has backed companies such as Cognito Therapeutics and Aeovian Pharmaceuticals. Its approach is particularly notable because it often helps form companies around promising science rather than only investing after formation, making it highly relevant for translational research with a long scientific runway.

The firm invests across Europe and the United States. It is especially relevant for neurotech and biotech companies working on ageing, neurodegeneration, or the biological drivers of chronic disease, where deep scientific engagement matters as much as capital.